The negative association of tumoural Mb expression and a pre-menopausal status further fits the interpretation of Mb as an oestrogen-silenced gene, as pre-menopausal patients (high oestrogen serum levels) have, in comparison with postmenopausal patients (lower oestrogen serum levels), tumours with lower Mb expression levels. This evidence concerns the gene MB and neoplasm.